Anthrax lethal toxin: A weapon of multisystem destruction

Cellular and Molecular Life Sciences

Volumn 61, Issue 22, 2004, Pages 2859-2865

  Agrawal, A ^a   Pulendran, B ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Anthrax lethal toxin; Dendritic cells; Innate immunity; Macrophages; MAPkinase

Indexed keywords

ANTHRAX TOXIN; ANTIGEN; B7 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ESTROGEN; GLUCOCORTICOID; HORMONE RECEPTOR; LETHAL TOXIN; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGESTERONE; PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ZINC;

APOPTOSIS; BACILLUS ANTHRACIS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPORT; CELL TYPE; CHEMICAL COMPOSITION; CYTOKINE RELEASE; DENDRITIC CELL; DESTRUCTION; DOWN REGULATION; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPOSURE; HOST; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; INHIBITION KINETICS; LETHAL GENE; LETHALITY; MACROPHAGE; MOLECULE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STIMULATION; STRESS; T LYMPHOCYTE; TOXIN ANALYSIS; WEAPON;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; DENDRITIC CELLS; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

ANTHRAX; BACILLUS ANTHRACIS;

EID: 11244260655     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4251-4     Document Type: Review

References (41)

1. Koch R. (1876) Die Etiologie der Milzbrand Krankheit gegrundet auf die Entwickelungsgeschichte des Bacillus anthracis. Beitr. Biol. Pflanz 2277-283
2. Friedlander A. M., Welkos S. L., Pitt M. L., Ezzell J. W., Worsham P. L., Rose K. J. et al. (1993) Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 67: 1239-1243
3. Friedlander A. M. (2000) Anthrax: clinical features, pathogenesis and potential biological warfare threat. Curr. Clin. Top. Infect. Dis. 20: 335-349
4. Cohen S., Mendelson I., Altboum Z., Kobiler D., Elhanany E., Bino T. et al. (2000) Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect. Immun. 68: 4549-4558
5. Brossier F. and Mock M. (2001) Toxins of Bacillus anthracis. Toxicon 39: 1747-1755
6. Miller C. J., Elliott J. L. and Collier R. J. (1999) Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38: 10432-10441
7. Nassi S., Collier R. J. and Finkelstein A. (2002) PA63 channel of anthrax toxin: an extended beta-barrel. Biochemistry 41: 1445-1450
8. Scobie H. M., Rainey G. J., Bradley K. A. and Young J. A. (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100: 5170-5174
9. Bradley K. A., Mogridge J., Mourez M., Collier R. J. and Young J. A. (2001) Identification of the cellular receptor for anthrax toxin. Nature 414: 225-229
10. Duesbery N. S., Resau J., Webb C. P., Koochekpour S., Koo H. M., Leppla S. H. et al. (2001) Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc. Natl. Acad. Sci. USA 98: 4089-4094
11. Duesbery N. S., Webb C. P., Leppla S. H., Gordon V. M., Klimpel K. R., Copeland T. D. et al. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280: 734-737
12. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M. and Montecucco C. (1999) Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine/threonine phosphorylation of MAPKS in cultured macrophages. J. Appl. Microbiol. 87: 288-292
13. Vitale G., Bernardi L., Napolitani G., Mock M. and Montecucco C. (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352: 739-745
14. Pezard C., Berche P. and Mock M. (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59: 3472-3477
15. Wade B. H., Wright G. G., Hewlett E. L., Leppla S. H. and Mandell G. L. (1985) Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc. Soc. Exp. Biol. Med. 179: 159-162
16. O'Brien J., Friedlander A., Dreier T., Ezzell J. and Leppla S. (1985) Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47: 306-310
17. Hoover D. L., Friedlander A. M., Rogers L. C., Yoon I. K., Warren R. L. and Cross A. S. (1994) Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect. Immun. 62: 4432-4439
18. Banchereau J. and Steinman R. M. (1998) Dendritic cells and the control of immunity. Nature 392: 245-252
19. Pulendran B., Palucka K. and Banchereau J. (2001) Sensing pathogens and tuning immune responses. Science 293: 253-256
20. Pulendran B. (2004) Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199: 227-250
21. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J. et al. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 171: 4984-4989
22. Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A. et al. (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172: 4733-4743
23. Dixon T. C., Fadl A. A., Koehler T. M., Swanson J. A. and Hanna P. C. (2000) Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cell Microbiol. 2: 453-463
24. Guidi-Rontani C., Levy M., Ohayon H. and Mock M. (2001) Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol. Microbiol. 42: 931-938
25. Welkos S., Little S., Friedlander A., Fritz D. and Fellows P. (2001) The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147: 1677-1685
26. Welkos S. L., Keener T. J. and Gibbs P. H. (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51: 795-800
27. Hanna P. C., Acosta D. and Collier R. J. (1993) On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. USA 90: 10198-10201
28. Pellizzari R., Guidi-Rontani C., Vitale G., Mock M. and Montecucco C. (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 462: 199-204
29. Erwin J. L., DaSilva L. M., Bavari S., Little S. F., Friedlander A. M. and Chanh T. C. (2001) Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 69: 1175-1177
30. Moayeri M., Haines D., Young H. A. and Leppla S. H. (2003) Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112: 670-682
31. Kalns J., Scruggs J., Millenbaugh N., Vivekananda J., Shealy D., Eggers J. et al. (2002) TNF receptor 1, IL-1 receptor and iNOS genetic knockout mice are not protected from anthrax infection. Biochem. Biophys. Res. Commun. 292: 41-44
32. Kim S. O., Jing Q., Hoebe K., Beutler B., Duesbery N. S. and Han J. (2003) Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-alpha. J. Biol. Chem. 278: 7413-74121
33. Park J. M., Greten F. R., Li Z. W. and Karin M. (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051
34. Hsu L. C., Park J. M., Zhang K., Luo J. L., Maeda S., Kaufman R. J. et al. (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345
35. Agrawal A., Lingappa J., Leppla S. H., Agrawal S., Jabbar A., Quinn C. et al. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334
36. Kirby J. E. (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72: 430-439
37. Webster J. I., Tonelli L. H., Moayeri M., Simons S. S. Jr, Leppla S. H. and Sternberg E. M. (2003) Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc Natl. Acad. Sci. USA 100: 5706-5711
38. McEwen B. S., Biron C. A., Brunson K. W., Bulloch K., Chambers W. H., Dhabhar F. S. et al. (1997) The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Brain Res. Rev. 23: 79-133
39. McKay L. I. and Cidlowski J. A. (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20: 435-459
40. Ruzek M. C., Pearce B. D., Miller A. H. and Biron C. A. (1999) Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162: 3527-3533
41. Popov S. G., Villasmil R., Bernardi J., Grene E., Cardwell J., Popova T. et al. (2002) Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527: 211-215